Sterling Investment Advisors, Ltd. Cerus Corp Transaction History

Sterling Investment Advisors, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$4.81 - $6.99 $4,810 - $6,990	-1,000 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$5.78 - $7.47 $8,670 - $11,205	-1,500 Reduced 60.0%	1,000 $6,000
Q3 2019 Oct 15, 2019	BUY	$4.86 - $6.05 $4,860 - $6,050	1,000 Added 66.67%	2,500 $13,000
Q1 2019 May 01, 2019	BUY	$5.16 - $6.85 $2,580 - $3,425	500 Added 50.0%	1,500 $9,000
Q2 2018 Jul 26, 2018	BUY	$5.19 - $7.25 $5,190 - $7,250	1,000 New	1,000 $6,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $351M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.